{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T15:02:38Z","timestamp":1766674958208,"version":"3.37.3"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T00:00:00Z","timestamp":1486598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171871","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T19:04:42Z","timestamp":1486667082000},"page":"e0171871","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17\u03b2-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models"],"prefix":"10.1371","volume":"12","author":[{"given":"Lucie Carolle","family":"Kenmogne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Maltais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Neveu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Pouliot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,2,9]]},"reference":[{"year":"2015","key":"ref1","article-title":"Canadian Cancer Statistics 2015"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer Statistics, 2015","volume":"65","author":"RL Siegel","year":"2015","journal-title":"Ca Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrurol.2010.231","article-title":"Blockade of testicular and adrenal androgens in prostate cancer treatment","volume":"8","author":"F Labrie","year":"2011","journal-title":"Nat Rev Urol"},{"key":"ref4","first-page":"359","article-title":"Compliance with hormonal treatment for prostate cancer","volume":"55","author":"AV Kaisary","year":"1995","journal-title":"Br J Hosp Med"},{"key":"ref5","first-page":"41","article-title":"Antiandrogens in tumor therapy","volume":"1","author":"F Neumann","year":"1982","journal-title":"Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/j.1552-4604.1989.tb03381.x","article-title":"Single and multiple dose pharmacokinetic evaluation of flutamide in normal geriatric volunteers","volume":"29","author":"E Radwanski","year":"1989","journal-title":"J Clin Pharm"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"F Labrie","year":"1991","journal-title":"Molecular and Cellular Endocrinology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.beem.2008.01.008","article-title":"Androgen biosynthetic pathways in the human prostate","volume":"22","author":"V Luu-The","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/pros.10139","article-title":"Differential expression of 17\u03b2-hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissues","volume":"53","author":"E Koh","year":"2002","journal-title":"Prostate"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.steroids.2007.10.009","article-title":"Proliferative effect of androst-4-ene-3,17-dione and its metabolites in the androgen-sensitive LNCaP cell line","volume":"73","author":"Y Laplante","year":"2008","journal-title":"Steroids"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/j.bmc.2011.06.003","article-title":"Development of 3-substituted-androsterone derivatives as potent inhibitors of 17\u03b2-hydroxysteroid dehydrogenase type 3","volume":"19","author":"R Maltais","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm010286y","article-title":"Synthesis and optimization of a new family of type 3 17\u03b2-hydroxysteroid dehydrogenase inhibitors by parallel liquid-phase chemistry","volume":"45","author":"R Maltais","year":"2002","journal-title":"J Med Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1021\/jm058179h","article-title":"Androsterone 3\u03b1-ether-3\u03b2-substituted and androsterone 3\u03b2-substituted derivatives as inhibitors of type 3 17\u03b2-hydroxysteroid dehydrogenase: chemical synthesis and structure-activity relationship","volume":"48","author":"B Tchedam-Ngatcha","year":"2005","journal-title":"J Med Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1016\/j.bmc.2015.07.049","article-title":"Design, chemical synthesis and biological evaluation of 3-spiromorpholinone\/3-spirocarbamate androsterone derivatives as inhibitors of 17\u03b2-hydroxysteroid dehydrogenase type 3","volume":"23","author":"GB Djigou\u00e9","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsbmb.2013.12.019","article-title":"In vitro and in vivo evaluation of a 3\u03b2-androsterone derivative as inhibitor of 17\u03b2-hydroxysteroid dehydrogenase type 3","volume":"141","author":"J Roy","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref16","first-page":"2861","article-title":"Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancer","volume":"54","author":"JP Gaddipati","year":"1994","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.18632\/oncotarget.6360","article-title":"A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer","volume":"7","author":"B Neveu","year":"2016","journal-title":"Oncotarget"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsbmb.2006.02.004","article-title":"Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women","volume":"99","author":"F Labrie","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2307\/3001469","article-title":"Extension of multiple range to group means with unequal numbers of replications","volume":"12","author":"CY Kramer","year":"1956","journal-title":"Biometrics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.ju.0000149989.01263.dc","article-title":"Cell lines used in prostate cancer research: A compendium of old and new lines \u2014 Part 2","volume":"173","author":"RE Sobel","year":"2005","journal-title":"J Urol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1158\/1078-0432.CCR-04-1990","article-title":"Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer","volume":"11","author":"M Sato","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"33968","DOI":"10.1038\/srep33968","article-title":"Bioluminescence microscopy as a method to measure single cell androgen receptor activity heterogeneous responses to antiandrogens","volume":"6","author":"P Jain","year":"2016","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mt.2012.259","article-title":"A molecular imaging system based on both transcriptional and genomic amplification to detect prostate cancer cells in vivo","volume":"21","author":"F Pouliot","year":"2013","journal-title":"Mol Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1677\/ERC-10-0022","article-title":"Differential expression of steroid 5\u03b1-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer","volume":"17","author":"K Das","year":"2010","journal-title":"Endocr-Rela Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ajpath.2014.04.010","article-title":"Castration induces up-regulation of intratumoral androgen biosynthesis and androgen receptor expression in an orthotopic VCaP human prostate cancer xenograft model","volume":"184","author":"M Knuuttila","year":"2014","journal-title":"Am J Pathol"},{"key":"ref26","first-page":"1383","article-title":"Functional characterization of mutant androgen receptors from androgen-independent prostate cancer","volume":"3","author":"MA Fenton","year":"1997","journal-title":"Clin Cancer Res"},{"key":"ref27","first-page":"2511","article-title":"Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist","volume":"59","author":"ME Taplin","year":"1999","journal-title":"Cancer Res"},{"key":"ref28","first-page":"149","article-title":"Novel mutations of androgen receptor A possible mechanism of bicalutamide withdrawal syndrome","volume":"63","author":"T Hara","year":"2003","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1073\/pnas.1107898108","article-title":"Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer","volume":"108","author":"KH Chang","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2015.05.010","article-title":"Mechanisms of drug resistance that target the androgen axis in castration resistant prostate cancer (CRPC)","volume":"153","author":"TM Penning","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jsbmb.2013.05.017","article-title":"Assessment of steroidogenesis and steroidogenic enzyme functions","volume":"137","author":"V Luu-The","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref32","article-title":"The activity of SN33638, an inhibitor of AKR1C3, on testosterone and 17\u03b2-estradiol production and function in castration-resistant prostate cancer and ER-positive breast cancer","volume":"4","author":"YD Yin","year":"2014","journal-title":"Front Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbrc.2016.01.190","article-title":"Human dehydrogenase\/reductase (SDR family) member 11 is a novel type of 17\u03b2-hydroxysteroid dehydrogenase","volume":"472","author":"S Endo","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1158\/1078-0432.CCR-11-0644","article-title":"Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone","volume":"17","author":"JL Mohler","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1210\/me.2005-0287","article-title":"Identification of the major oxidative 3\u03b1-hydroxysteroid dehydrogenase in human prostate that converts 5\u03b1-androstane-3\u03b1, 17\u03b2-diol to 5\u03b1-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease","volume":"20","author":"DR Bauman","year":"2006","journal-title":"Mol Endocrinol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-10-1343","article-title":"Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer","volume":"71","author":"JL Mohler","year":"2011","journal-title":"Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/srep01528","article-title":"Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer","volume":"3","author":"F Ishizaki","year":"2013","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nm0497-402","article-title":"Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice","volume":"3","author":"KA Klein","year":"1997","journal-title":"Nat Med"},{"key":"ref39","first-page":"212","article-title":"Steroid hormone synthetic pathways in prostate cancer","volume":"2","author":"EA Mostaghel","year":"2013","journal-title":"Transl Androl Urol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"33466","DOI":"10.1074\/jbc.M703370200","article-title":"UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgenresponse in prostate cancer LNCaP cells","volume":"282","author":"S Chouinard","year":"2007","journal-title":"J Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:15:17Z","timestamp":1589030117000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171871"}},"subtitle":[],"editor":[{"given":"Zoran","family":"Culig","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,9]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171871","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,2,9]]}}}